RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Memory Disorders
Accession: DOID:9008023
browse the term
Definition: Disturbances in registering an impression, in the retention of an acquired impression, or in the recall of an impression. Memory impairments are associated with DEMENTIA; CRANIOCEREBRAL TRAUMA; ENCEPHALITIS; ALCOHOLISM (see also ALCOHOL AMNESTIC DISORDER); SCHIZOPHRENIA; and other conditions.
Synonyms: exact_synonym: Age Related Memory Disorders; Age-Related Memory Disorder; Cognitive Retention Disorder; Cognitive Retention Disorders; Memory Deficit; Memory Deficits; Memory Disorder; Memory Loss; Memory Losses; Semantic Memory Disorder; Semantic Memory Disorders; Spatial Memory Disorder; Spatial Memory Disorders; memory impairment
related_synonym: MEMORY IMPAIRMENT, SUSCEPTIBILITY TO
primary_id: MESH:D008569
xref: EFO:0001072
GViewer not supported for the selected species.
G
Abl1
ABL proto-oncogene 1, non-receptor tyrosine kinase
treatment
ISO
RGD
PMID:18559370
RGD:8693418
NCBI chrNW_004955513:652,048...799,182
Ensembl chrNW_004955513:653,252...799,239
G
Ache
acetylcholinesterase (Cartwright blood group)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18599028
NCBI chrNW_004955573:79,606...85,799
Ensembl chrNW_004955573:80,298...85,799
G
Adk
adenosine kinase
ISO
RGD
PMID:22521820
RGD:6482646
NCBI chrNW_004955437:17,279,541...17,786,140
Ensembl chrNW_004955437:17,279,240...17,786,079
G
Adra1a
adrenoceptor alpha 1A
ISO
associated with brain injuries
RGD
PMID:20974230
RGD:5688366
NCBI chrNW_004955403:49,394,173...49,485,881
Ensembl chrNW_004955403:49,399,127...49,485,934
G
Agap2
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2
ISO
RGD
PMID:21632930
RGD:13838852
NCBI chrNW_004955458:5,436,544...5,448,201
Ensembl chrNW_004955458:5,436,630...5,448,057
G
Akap5
A-kinase anchoring protein 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18711127
NCBI chrNW_004955466:5,411,190...5,422,043
Ensembl chrNW_004955466:5,411,650...5,412,960
G
Akt1
AKT serine/threonine kinase 1
treatment
ISO
RGD
PMID:29157831
RGD:401940181
NCBI chrNW_004955538:3,208,711...3,224,386
Ensembl chrNW_004955538:3,208,710...3,229,904
G
Anapc2
anaphase promoting complex subunit 2
ISO
RGD
PMID:21191042
RGD:14696672
NCBI chrNW_004955513:5,183,472...5,194,253
Ensembl chrNW_004955513:5,183,472...5,194,253
G
Apoc1
apolipoprotein C1
ISO
RGD
PMID:11714102
RGD:1578426
NCBI chrNW_004955555:2,005,962...2,007,239
G
Apoe
apolipoprotein E
ISO
DNA:missense mutations, haplotypes:cds:p.C112R, p.R158C (human)
RGD
PMID:8584214 PMID:11714102
RGD:12904706 RGD:1578426
NCBI chrNW_004955555:1,998,170...2,002,003
Ensembl chrNW_004955555:1,999,711...2,001,888
G
App
amyloid beta precursor protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15364477 PMID:18191838 PMID:18599028 PMID:19664757 PMID:19770021 PMID:20816828 PMID:22484447 PMID:23827522 PMID:24858312 PMID:25213453 PMID:25881725 PMID:26420483 PMID:26480858 PMID:27306655 PMID:27567873 PMID:28448946 PMID:29729307 PMID:35247505 More...
NCBI chrNW_004955407:25,725,259...25,973,582
Ensembl chrNW_004955407:25,722,849...25,974,268
G
Bcl2
BCL2 apoptosis regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17967740
NCBI chrNW_004955402:46,911,125...47,084,214
Ensembl chrNW_004955402:46,916,266...47,084,485
G
Bdnf
brain derived neurotrophic factor
treatment
ISO
ClinVar Annotator: match by term: Memory impairment, susceptibility to associated with Subarachnoid Hemorrhage
ClinVar RGD
PMID:12140781 PMID:12161822 PMID:12553913 PMID:12836135 PMID:12888803 PMID:15115760 PMID:15337662 PMID:16152572 PMID:16172806 PMID:16222333 PMID:16344533 PMID:16389585 PMID:20075215 PMID:24033266 PMID:25741868 PMID:26822402 PMID:28492532 PMID:29157831 PMID:29704550 More...
RGD:401940181 RGD:401960858 RGD:401960859
NCBI chrNW_004955476:6,773,244...6,822,201
Ensembl chrNW_004955476:6,772,088...6,822,588
G
Cacna1d
calcium voltage-gated channel subunit alpha1 D
ISO
RGD
PMID:12591156
RGD:704382
NCBI chrNW_004955430:3,450,151...3,796,983
Ensembl chrNW_004955430:3,268,953...3,794,592
G
Caly
calcyon neuron specific vesicular protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30753204
NCBI chrNW_004955477:10,983,602...10,993,371
Ensembl chrNW_004955477:10,983,133...10,987,331
G
Chd1
chromodomain helicase DNA binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30728766
NCBI chrNW_004955418:14,200,618...14,268,361
Ensembl chrNW_004955418:14,200,617...14,268,361
G
Chrm1
cholinergic receptor muscarinic 1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12483218 PMID:21682298
RGD:734777
NCBI chrNW_004955599:349,744...356,714
Ensembl chrNW_004955599:349,744...356,714
G
Chrna7
cholinergic receptor nicotinic alpha 7 subunit
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:18848931
NCBI chrNW_004955416:30,687,518...30,798,700
Ensembl chrNW_004955416:30,687,478...30,798,700
G
Cnr1
cannabinoid receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29294249
NCBI chrNW_004955411:15,052,151...15,077,320
Ensembl chrNW_004955411:15,052,163...15,077,320
G
Comt
catechol-O-methyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28195063
NCBI chrNW_004955442:18,130,282...18,152,153
Ensembl chrNW_004955442:18,130,987...18,137,412
G
Cpe
carboxypeptidase E
ISO
RGD
PMID:18570185
RGD:6483325
NCBI chrNW_004955403:39,862,893...39,971,902
Ensembl chrNW_004955403:39,862,191...39,971,902
G
Creb1
cAMP responsive element binding protein 1
treatment
ISO
protein:decreased expression:hippocampus associated with Subarachnoid Hemorrhage associated with morphine dependence associated with alcohol use disorder;mRNA:decreased expression:hippocampus
RGD
PMID:14670355 PMID:16598705 PMID:26822402 PMID:29157831 PMID:29704550 PMID:34427953 More...
RGD:10059396 RGD:401940181 RGD:401959600 RGD:401959605 RGD:401960858 RGD:401960859
NCBI chrNW_004955457:7,424,403...7,490,630
Ensembl chrNW_004955457:7,431,736...7,491,149
G
Cx3cr1
C-X3-C motif chemokine receptor 1
ISO
RGD
PMID:23855980
RGD:9491766
NCBI chrNW_004955427:24,691,206...24,705,599
Ensembl chrNW_004955427:24,701,073...24,707,230
G
Drd2
dopamine receptor D2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21592505
NCBI chrNW_004955412:15,054,255...15,114,558
Ensembl chrNW_004955412:15,054,038...15,114,573
G
Egr1
early growth response 1
treatment
ISO
associated with Congenital Hypothyroidism
RGD
PMID:22192600
RGD:10395310
NCBI chrNW_004955418:2,001,509...2,005,269
Ensembl chrNW_004955418:2,002,699...2,005,007
G
Gabra5
gamma-aminobutyric acid type A receptor subunit alpha5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20180861
NCBI chrNW_004955533:2,563,499...2,631,086
Ensembl chrNW_004955533:2,563,319...2,631,289
G
Git1
GIT ArfGAP 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21499268
NCBI chrNW_004955481:3,671,728...3,681,279
Ensembl chrNW_004955481:3,670,111...3,685,051
G
Grpr
gastrin releasing peptide receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17097693
NCBI chrNW_004955519:2,032,500...2,063,292
Ensembl chrNW_004955519:2,032,500...2,063,292
G
Hdac2
histone deacetylase 2
treatment
ISO
RGD
PMID:22388814
RGD:9590324
NCBI chrNW_004955526:2,739,099...2,759,640
Ensembl chrNW_004955526:2,728,377...2,759,707
G
Hif1a
hypoxia inducible factor 1 subunit alpha
treatment
ISO
RGD
PMID:22547371
RGD:10402407
NCBI chrNW_004955466:8,000,311...8,022,497
Ensembl chrNW_004955466:8,000,044...8,022,497
G
Hrh3
histamine receptor H3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16488453
NCBI chrNW_004955528:1,819,247...1,826,707
Ensembl chrNW_004955528:1,819,247...1,826,707
G
Htr1a
5-hydroxytryptamine receptor 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12591222
NCBI chrNW_004955446:4,913,181...4,917,726
Ensembl chrNW_004955446:4,913,884...4,915,146
G
Htr2a
5-hydroxytryptamine receptor 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29294249
NCBI chrNW_004955431:583,165...646,991
Ensembl chrNW_004955431:580,713...647,345
G
Htr6
5-hydroxytryptamine receptor 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19733250
NCBI chrNW_004955452:323,641...338,312
G
Htr7
5-hydroxytryptamine receptor 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21859099
NCBI chrNW_004955425:2,321,420...2,420,420
Ensembl chrNW_004955425:2,321,420...2,420,530
G
Igf2
insulin like growth factor 2
treatment
ISO
CTD Direct Evidence: therapeutic
RGD CTD
PMID:21270887 PMID:24012657
RGD:10402554
NCBI chrNW_004955422:13,880,525...13,907,963
Ensembl chrNW_004955422:13,880,471...13,888,566
G
Il1b
interleukin 1 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21290410
NCBI chrNW_004955470:1,486,936...1,491,888
Ensembl chrNW_004955470:1,486,967...1,491,947
G
Ins
insulin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:9264093
NCBI chrNW_004955422:13,909,408...13,910,419
Ensembl chrNW_004955422:13,909,407...13,910,419
G
Kl
klotho
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25309793 PMID:25550330
NCBI chrNW_004955431:12,782,913...12,833,215
Ensembl chrNW_004955431:12,782,846...12,833,215
G
Lnpep
leucyl and cystinyl aminopeptidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11730987
NCBI chrNW_004955418:15,631,703...15,718,711
Ensembl chrNW_004955418:15,640,143...15,718,711
G
LOC102026469
HLA class II histocompatibility antigen, DP beta 1 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14975599
NCBI chrNW_004955437:1,655,092...1,666,552
Ensembl chrNW_004955437:1,635,538...1,669,042
G
Magi2
membrane associated guanylate kinase, WW and PDZ domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25653350
NCBI chrNW_004955410:6,739,115...7,295,027
Ensembl chrNW_004955410:6,400,242...7,294,924
G
Mapk1
mitogen-activated protein kinase 1
treatment
ISO
associated with Subarachnoid Hemorrhage
RGD
PMID:26822402 PMID:29157831
RGD:401940181 RGD:401960859
NCBI chrNW_004955442:17,284,232...17,380,026
Ensembl chrNW_004955442:17,284,232...17,380,020
G
Mapk3
mitogen-activated protein kinase 3
treatment
ISO
associated with Subarachnoid Hemorrhage
RGD
PMID:26822402 PMID:29157831
RGD:401940181 RGD:401960859
NCBI chrNW_004955493:6,870,699...6,876,836
Ensembl chrNW_004955493:6,869,668...6,879,152
G
Mapt
microtubule associated protein tau
ISO
ClinVar Annotator: match by term: Memory impairment
ClinVar
PMID:7783864 PMID:7936288 PMID:8940276 PMID:9088499 PMID:9392579 PMID:9641683 PMID:10202939 PMID:10329720 PMID:10443890 PMID:10446810 PMID:11255441 PMID:11402146 PMID:11641718 PMID:11708988 PMID:11912108 PMID:11971081 PMID:11971082 PMID:12847166 PMID:14755449 PMID:15372253 PMID:17923640 PMID:18525295 PMID:19365643 PMID:19766248 PMID:19786698 PMID:19884572 PMID:19914360 PMID:20045477 PMID:23680655 PMID:23885714 PMID:25683866 PMID:25741868 PMID:26136155 PMID:26467025 PMID:27594586 PMID:28097206 PMID:28492532 More...
NCBI chrNW_004955478:10,222,439...10,271,439
Ensembl chrNW_004955478:10,225,823...10,271,442
G
Mdk
midkine
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19217924
NCBI chrNW_004955422:1,655,351...1,657,026
Ensembl chrNW_004955422:1,655,358...1,657,044
G
Mif
macrophage migration inhibitory factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20177408
NCBI chrNW_004955455:8,367,566...8,368,460
Ensembl chrNW_004955455:8,367,566...8,368,460
G
Ncam1
neural cell adhesion molecule 1
treatment
ISO
associated with alcohol use disorder
RGD
PMID:16207289
RGD:401959613
NCBI chrNW_004955412:14,630,109...14,923,847
Ensembl chrNW_004955412:14,630,443...14,923,926
G
Nos1
nitric oxide synthase 1
ISO
associated with Status Epilepticus
RGD
PMID:17549628
RGD:1642140
NCBI chrNW_004955455:13,797,557...13,978,402
Ensembl chrNW_004955455:13,797,545...13,972,566
G
Npy
neuropeptide Y
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:2611661
NCBI chrNW_004955410:26,348,388...26,355,232
Ensembl chrNW_004955410:26,348,504...26,355,297
G
Nqo2
N-ribosyldihydronicotinamide:quinone dehydrogenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20861374
NCBI chrNW_004955465:10,186,928...10,200,098
Ensembl chrNW_004955465:10,186,928...10,200,237
G
Ntf4
neurotrophin 4
ISO
RGD
PMID:10869436
RGD:737722
NCBI chrNW_004955559:1,647,685...1,650,553
Ensembl chrNW_004955559:1,647,685...1,650,553
G
Pnoc
prepronociceptin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10401555
NCBI chrNW_004955403:50,735,567...50,755,892
Ensembl chrNW_004955403:50,735,390...50,755,902
G
Prkn
parkin RBR E3 ubiquitin protein ligase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12915482
NCBI chrNW_004955439:18,664,230...19,953,358
Ensembl chrNW_004955439:18,664,379...19,951,152
G
Prl
prolactin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:36100143
NCBI chrNW_004955483:4,495,257...4,503,377
G
Psen1
presenilin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25213453 PMID:27567873 PMID:28448946
NCBI chrNW_004955523:2,128,529...2,210,737
Ensembl chrNW_004955523:2,128,529...2,210,737
G
Rel
REL proto-oncogene, NF-kB subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20477932
NCBI chrNW_004955424:22,909,035...22,939,651
Ensembl chrNW_004955424:22,911,541...22,939,651
G
Sigmar1
sigma non-opioid intracellular receptor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15451042
NCBI chrNW_004955472:1,493,896...1,496,377
Ensembl chrNW_004955472:1,493,896...1,496,377
G
Slc17a6
solute carrier family 17 member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21295146
NCBI chrNW_004955476:2,813,368...2,854,371
Ensembl chrNW_004955476:2,813,368...2,854,514
G
Slc17a7
solute carrier family 17 member 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21295146
NCBI chrNW_004955559:1,399,182...1,409,074
Ensembl chrNW_004955559:1,399,182...1,409,134
G
Slc6a3
solute carrier family 6 member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17992686
NCBI chrNW_004955504:721,470...747,553
Ensembl chrNW_004955504:721,429...747,630
G
Slc6a4
solute carrier family 6 member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18661256 PMID:18686203
NCBI chrNW_004955481:3,088,440...3,122,421
Ensembl chrNW_004955481:3,088,416...3,125,711
G
Sphk2
sphingosine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24859201
NCBI chrNW_004955559:1,921,479...1,929,450
Ensembl chrNW_004955559:1,917,301...1,928,493
G
Stat3
signal transducer and activator of transcription 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17928813
NCBI chrNW_004955451:16,320,326...16,348,505
Ensembl chrNW_004955451:16,319,904...16,357,687
G
Syp
synaptophysin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21295146
NCBI chrNW_004955543:675,294...689,579
Ensembl chrNW_004955543:675,294...689,686
G
Tyrobp
transmembrane immune signaling adaptor TYROBP
ISO
ClinVar Annotator: match by term: Memory impairment
ClinVar
PMID:9536098 PMID:17576681 PMID:25741868 PMID:28492532 PMID:29930232
NCBI chrNW_004955468:2,673,657...2,677,633
Ensembl chrNW_004955468:2,673,980...2,677,321
G
Vegfa
vascular endothelial growth factor A
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20801723
NCBI chrNW_004955437:9,527,445...9,541,908
G
App
amyloid beta precursor protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12642396
NCBI chrNW_004955407:25,725,259...25,973,582
Ensembl chrNW_004955407:25,722,849...25,974,268
G
Arc
activity regulated cytoskeleton associated protein
treatment
ISO
RGD
PMID:24012642
RGD:401938610
NCBI chrNW_004955454:1,379,998...1,383,414
Ensembl chrNW_004955454:1,379,998...1,383,414
G
Bche
butyrylcholinesterase
ISO
RGD
PMID:21771623
RGD:5688134
NCBI chrNW_004955448:15,327,374...15,396,827
Ensembl chrNW_004955448:15,329,273...15,396,970
G
Bdnf
brain derived neurotrophic factor
treatment
ISO
protein:decreased expression:amygdala, hippocampus, prefrontal cortex
RGD
PMID:25061594 PMID:28716085 PMID:31400468
RGD:10059361 RGD:401960865 RGD:401960871
NCBI chrNW_004955476:6,773,244...6,822,201
Ensembl chrNW_004955476:6,772,088...6,822,588
G
Creb1
cAMP responsive element binding protein 1
treatment
ISO
protein:decreased phosphorylation:amygdala, hippocampus, prefrontal cortex
RGD
PMID:28716085 PMID:31400468
RGD:401960865 RGD:401960871
NCBI chrNW_004955457:7,424,403...7,490,630
Ensembl chrNW_004955457:7,431,736...7,491,149
G
Csf2
colony stimulating factor 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:8877002
NCBI chrNW_004955408:3,452,009...3,454,255
Ensembl chrNW_004955408:3,451,965...3,454,312
G
Drd3
dopamine receptor D3
ISO
RGD
PMID:15619116
RGD:7175071
NCBI chrNW_004955427:14,219,519...14,252,178
Ensembl chrNW_004955427:14,219,594...14,252,178
G
Gja1
gap junction protein alpha 1
ISO
RGD
PMID:22665389
RGD:7207267
NCBI chrNW_004955436:3,612,533...3,618,095
Ensembl chrNW_004955436:3,612,533...3,618,095
G
Gnai1
G protein subunit alpha i1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11350863
NCBI chrNW_004955410:5,388,184...5,467,022
Ensembl chrNW_004955410:5,388,184...5,467,022
G
Gnai3
G protein subunit alpha i3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11350863
NCBI chrNW_004955435:12,965,006...13,005,614
Ensembl chrNW_004955435:12,965,006...13,005,614
G
Grp
gastrin releasing peptide
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:11564462
NCBI chrNW_004955402:43,382,608...43,393,452
Ensembl chrNW_004955402:43,382,552...43,393,463
G
Hrh3
histamine receptor H3
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11125734 PMID:17276409
RGD:1626421
NCBI chrNW_004955528:1,819,247...1,826,707
Ensembl chrNW_004955528:1,819,247...1,826,707
G
Htr7
5-hydroxytryptamine receptor 7
ISO
RGD
PMID:18570192
RGD:6482184
NCBI chrNW_004955425:2,321,420...2,420,420
Ensembl chrNW_004955425:2,321,420...2,420,530
G
Il1a
interleukin 1 alpha
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:8003924
NCBI chrNW_004955470:1,527,710...1,538,418
Ensembl chrNW_004955470:1,527,674...1,538,466
G
Il2
interleukin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8241462
NCBI chrNW_004955428:18,163,010...18,168,157
Ensembl chrNW_004955428:18,162,467...18,168,265
G
Il6
interleukin 6
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:9189931
NCBI chrNW_004955410:25,079,835...25,084,390
G
Ngf
nerve growth factor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16405025 PMID:19694610
NCBI chrNW_004955435:18,581,889...18,633,330
Ensembl chrNW_004955435:18,581,808...18,601,059
G
Pdyn
prodynorphin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:7768285
NCBI chrNW_004955415:13,106,087...13,119,497
Ensembl chrNW_004955415:13,106,062...13,119,515
G
Pomc
proopiomelanocortin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:2841920
NCBI chrNW_004955469:7,217,233...7,220,401
Ensembl chrNW_004955469:7,217,363...7,220,386
G
Prep
prolyl endopeptidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8691432
NCBI chrNW_004955411:30,698,112...30,797,096
Ensembl chrNW_004955411:30,698,112...30,835,923
G
Sigmar1
sigma non-opioid intracellular receptor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12028363
NCBI chrNW_004955472:1,493,896...1,496,377
Ensembl chrNW_004955472:1,493,896...1,496,377
G
Tac1
tachykinin precursor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:7562510 PMID:9521815 PMID:20600432
NCBI chrNW_004955432:13,991,647...13,999,665
Ensembl chrNW_004955432:13,991,414...13,999,728
G
Trh
thyrotropin releasing hormone
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:7562510 PMID:7617693 PMID:8405091
NCBI chrNW_004955429:17,487,275...17,489,385
G
Prep
prolyl endopeptidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18318186
NCBI chrNW_004955411:30,698,112...30,797,096
Ensembl chrNW_004955411:30,698,112...30,835,923
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO
RGD
PMID:18523723
RGD:2300277
NCBI chrNW_004955406:25,077,988...25,086,259
Ensembl chrNW_004955406:25,079,945...25,086,171
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all